SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-18-000281
Filing Date
2018-02-14
Accepted
2018-02-14 16:01:14
Documents
1
Group Members
ABRAMS CAPITAL PARTNERS II, L.P.ABRAMS CAPITAL PARTNERS II, LLCDAVID ABRAMS

Document Format Files

Seq Description Document Type Size
1 schedule13ga.htm SC 13G/A 67757
  Complete submission text file 0000929638-18-000281.txt   69443
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78786 | Film No.: 18612113
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116 617-646-6100
ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001358706 (see all company filings)

IRS No.: 204043368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A